These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 17990450
41. [Effect of combination of syndrome differentiation depending treatment and chemotherapy on prognostic factors in treating mid-late patients with non-small call lung cancer]. Li LN, Liu WS, Xu K. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Aug; 23(8):575-9. PubMed ID: 14503053 [Abstract] [Full Text] [Related]
42. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer. Westeel V, Quoix E, Moro-Sibilot D, Mercier M, Breton JL, Debieuvre D, Richard P, Haller MA, Milleron B, Herman D, Level MC, Lebas FX, Puyraveau M, Depierre A, French Thoracic Oncology Collaborative Group (GCOT). J Natl Cancer Inst; 2005 Apr 06; 97(7):499-506. PubMed ID: 15812075 [Abstract] [Full Text] [Related]
43. [Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer]. Ren H, Wang LH, Wang XZ, Lü JM, Ji W, Zhou ZM, Ou GF, Yin WB. Zhonghua Zhong Liu Za Zhi; 2009 Feb 06; 31(2):143-7. PubMed ID: 19538894 [Abstract] [Full Text] [Related]
44. [Clinical observation on treatment of 34 advanced gastric carcinoma patients by chemotherapy of DCF regimen combined with Fuzheng Hewei Decoction]. Wang HZ, Wang HB, Gao H. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Oct 06; 27(10):927-9. PubMed ID: 17990465 [Abstract] [Full Text] [Related]
45. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I. Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE. J Clin Oncol; 2008 Apr 10; 26(11):1886-92. PubMed ID: 18398154 [Abstract] [Full Text] [Related]
46. Comprehensive TCM treatments combined with chemotherapy for advanced non-small cell lung cancer: A randomized, controlled trial. Xiao Z, Chen Z, Han R, Lu L, Li Z, Lin J, Hu L, Huang X, Lin L. Medicine (Baltimore); 2021 May 07; 100(18):e25690. PubMed ID: 33950949 [Abstract] [Full Text] [Related]
47. Clinical observation on the combined treatment of 57 cases of non-small cell lung cancer using argon-helium cryosurgery and Chinese herbal medicine. Hu KW, Li QW, Zuo MH, Sun T, Jiang M. Chin J Integr Med; 2007 Sep 07; 13(3):224-7. PubMed ID: 17898956 [Abstract] [Full Text] [Related]
48. [Effect of Fructus Bruceae oil emulsion on cellular immune function and quality of life in patients with non-small cell lung cancer]. Tian HQ, Yu SY, Wang B. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Feb 07; 27(2):157-9. PubMed ID: 17343006 [Abstract] [Full Text] [Related]
49. Chinese herbal medicine as maintenance therapy for improving the quality of life for advanced non-small cell lung cancer patients. Han Y, Wang H, Xu W, Cao B, Han L, Jia L, Xu Y, Zhang Q, Wang X, Zhang G, Yu M, Yang G. Complement Ther Med; 2016 Feb 07; 24():81-9. PubMed ID: 26860807 [Abstract] [Full Text] [Related]
52. Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer. Kwon JH, Kim JH, Lee JA, Shin HC, Kim HJ, Song HH, Jung JY, Kim HY, Choi DR, Kim HS, Park YI, Zang DY. Cancer Chemother Pharmacol; 2010 Oct 07; 66(5):889-97. PubMed ID: 20091311 [Abstract] [Full Text] [Related]
53. FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer. Cohen MH, Gootenberg J, Keegan P, Pazdur R. Oncologist; 2007 Jun 07; 12(6):713-8. PubMed ID: 17602060 [Abstract] [Full Text] [Related]
54. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group. Hallqvist A, Wagenius G, Rylander H, Brodin O, Holmberg E, Lödén B, Ewers SB, Bergström S, Wichardt-Johansson G, Nilsson K, Ekberg L, Sederholm C, Nyman J. Lung Cancer; 2011 Feb 07; 71(2):166-72. PubMed ID: 20541833 [Abstract] [Full Text] [Related]
56. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group. J Thorac Cardiovasc Surg; 2003 Feb 07; 125(2):254-60. PubMed ID: 12579093 [Abstract] [Full Text] [Related]
57. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions]. Cheng C, Wu YL, Gu LJ, Chen G, Weng YM, Feng WN, Zhong WZ. Ai Zheng; 2005 Jul 07; 24(7):846-9. PubMed ID: 16004813 [Abstract] [Full Text] [Related]
58. Could Jinfukang alleviate the chemotherapy-related adverse effects in non-small cell lung cancer patients?: A protocol for a double-blind, randomized controlled trial. Zheng X, Wang W, Wang G, Liu S. Medicine (Baltimore); 2021 Jul 16; 100(28):e25002. PubMed ID: 34260519 [Abstract] [Full Text] [Related]
59. [Effect of oleum fructus brucease injection via bronchial arterial infusion in treating advanced lung cancer]. Bai ZP, Deng XS. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Aug 16; 30(8):838-40. PubMed ID: 21038653 [Abstract] [Full Text] [Related]
60. [Study on effect of moxibustion and guben yiliu III combined with chemotherapy in treating middle-late stage malignant tumor]. Liu J, Yu RC, Rao XQ. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Apr 16; 21(4):262-4. PubMed ID: 12577352 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]